Blood Component Therapy

Whole blood, packed red blood cells (RBC) to random donor platelet packs Pheresis, platelets, fresh frozen plasma, albumin, clotting factors, autotransfusion
Blood Component therapy is used for the management of various hematologic diseases. Intravenous (IV) administration of blood and blood products used to restore circulating volume and replace the cellular components of blood. Advances in medical technology have improved the safety of radiation sources for blood transfusion. Blood is usually written in the ABO system, Rh system, and human leukocyte antigen found on tissue cells, blood leukocytes and platelets. Day has special blood component therapy essentially replaced the blood transfusion practice. Specific components can consist of red cells, fresh frozen plasma, platelets, granulocytes, special coagulation factors and expanders, eg albumin and plasma protein fraction. The use of blood components, extended access to substitution treatment for more patients with lower risk of side effects.

Several types of transfusion options: (1) homology (the traditional method using random donors), (2) autologous (using the method of blood products donated by patients for their own use, either by planned preprocedure blood donations that are imposed or required to collect blood that consists of collecting, filtering, and then returns the patient's own blood lost during surgery or acute trauma using automatic "device cell saver") and (3) The director of transfusion (donating blood for one person is targeted to specific recipients). Blood and blood component therapy can be safely administered by qualified nurses in hospitals, outpatient care and home environments.